¶¶زُ¶جتسئµ

header-logo
GettyImages-609179959-hero
headshot

Mary M. Horowitz, MD, MS

Professor and Deputy Cancer Center Director; Robert A. Uihlein, Jr. Chair in Hematologic Research; Associate Director of Genomics; Scientific Director Emeritus, CIBMTR

view physician profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English

Education

  • MD - Doctor of Medicine
  • MS

Biography

Dr. Mary Horowitz currently holds the Robert A. Uihlein, Jr. Chair in Hematologic Research and is a tenured Professor of Medicine at the ¶¶زُ¶جتسئµ (¶¶زُ¶جتسئµ), where she is also an active blood and marrow transplant physician. She is also Chief Scientific Director of the Center for International Blood and Marrow Transplant Research. She received ¶¶زُ¶جتسئµ’s Distinguished Service Award in June 2006, ¶¶زُ¶جتسئµ’s highest honor. In 2010, Dr. Horowitz received the American Society of Hematology Mentor Award. The award recognizes scientists who have dedicated their life to the process of guiding, supporting and promoting the training and career development of their junior colleagues. In 2014, Dr. Horowitz received the American Society of Blood and Marrow Transplant’s Lifetime Achievement Award in recognition of her contributions to the advancement of transplantation as a therapy for life-threatening diseases.

Research Interests

Dr. Horowitz is a member of the editorial boards of the journals Blood, Bone Marrow Transplantation, and Biology of Blood and Marrow Transplantation. She has served on the Board of Directors of the National Marrow Donor Program (NMDP) and as a member of the NMDP’s International Affairs Committee and, Research and Publications committees. Dr. Horowitz has served on the National Cancer Institute’s Cancer Clinical Investigation Review Committee, as well as on numerous advisory committees for public and private agencies, including the Data Safety and Monitoring Board of the National Heart Lung and Blood Institute’s Cord Blood Transplant Study, the Scientific Tumor Advisory Committee of the United Network for Organ Sharing, the Advisory Committee for the National Institute for Allergy and Infectious Disease Immune Tolerance Network and the 2005 Institute of Medicine Panel for Cord Blood Transplantation. She is the Principal Investigator of the Data and Coordinating Center of the U.S. Blood and Marrow Transplant Clinical Trials Network. She is also the Research and Project Director of the U.S. Stem Cell Therapeutic Outcomes Database, a component of the C.W. Bill Young Cell Transplantation Program, charged with collecting and assessing outcome data for all U.S. allogeneic transplants.

Dr. Horowitz has given more than 200 invited presentations on the subject of hematopoietic stem cell transplantation. Her research focuses on analysis of transplant outcomes with more than 250 papers in the biomedical literature.

Publications

  • (Abedin S, Martens MJ, Bolaños-Meade J, Al Malki MM, Lian Q, Runaas L, Elmariah H, Gooptu M, Larkin KT, Shaffer BC, Loren AW, Solh M, Alousi AM, Jamy OH, Perales MA, Rezvani A, Bhatt A, El Jurdi N, Yao JM, Applegate K, Kean LS, Efebera YA, Reshef R, Clark W, Leifer E, Saber W, Horowitz MM, Jones RJ, Holtan SG, Hamadani M.) Blood Adv. 2025 Jul 22;9(14):3495-3501 PMID: 40305657 PMCID: PMC12274666 SCOPUS ID: 2-s2.0-105011266148 04/30/2025

  • (Sorror ML, Saber W, Logan B, Geller N, Bellach A, Kou J, Wood W, McCarty JM, Knight TG, Runaas L, Johnston L, Walston J, Nakamura R, Jarrett L, Mishra A, Uberti J, Dahi PB, Saultz JN, McCurdy SR, Morris LE, Imus PH, Hogan WJ, Nadiminti K, Bhatt VR, Olin R, Maakaron J, Sobecks R, Wall SA, Mattila D, Protz B, Devine SM, Horowitz MM, Artz AS.) Blood Adv. 2025 Jul 08;9(13):3268-3280 PMID: 40101246 PMCID: PMC12246602 SCOPUS ID: 2-s2.0-105009768260 03/18/2025

  • (Levis MJ, Hamadani M, Logan BR, Jones RJ, Singh AK, Litzow MR, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh MM, Mishra A, Muffly LS, Kim HJ, Stelljes M, Najima Y, Onozawa M, Thomson KJ, Chen C, Hasabou N, Rosales M, Hill JE, Gill SC, Nuthethi R, King D, Mendizabal AM, Devine SM, Horowitz MM, Chen YB.) Blood Adv. 2025 Jul 01 PMID: 40590852 07/01/2025

  • (Bhatt NS, Borogovac A, Efebera YA, DeSalvo AM, Devine SM, Foley A, Stewart V, Hamilton BK, Heuer M, Molfenter T, Plastaras JP, Ragon BK, Wall SA, Broglie L, Juckett MB, Khera N, Horowitz MM, DeZern AE.) Blood Adv. 2025 Jun 24 PMID: 40554428 06/24/2025

  • (Bröckelmann PJ, Cliff ERS, Iacoboni G, Simon F, Horowitz MM, Keating A, Mateos MV, Mohty M, Sidana S, Song Y, Wingard JR, Thanarajasingam G.) Lancet Haematol. 2025 Jun;12(6):e470-e481 PMID: 40447355 05/31/2025

  • (Wirbel J, Andermann TM, Brooks EF, Evans L, Groth A, Dvorak M, Chakraborty M, Palushaj B, Reynolds GZM, Porter IE, Al Malki M, Rezvani A, Gooptu M, Elmariah H, Runaas L, Fei T, Martens MJ, Bolaños-Meade J, Hamadani M, Holtan S, Jenq R, Peled JU, Horowitz MM, Poston KL, Saber W, Kean LS, Perales MA, Bhatt AS.) Cell Rep Methods. 2025 May 19;5(5):101030 PMID: 40300608 PMCID: PMC12146642 SCOPUS ID: 2-s2.0-105003827989 04/30/2025

  • (Levis MJ, Hamadani M, Logan BR, Jones RJ, Singh AK, Litzow MR, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Oshima MU, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly LS, Kim HJ, Stelljes M, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Chen C, Hasabou N, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Mendizabal A, Devine SM, Horowitz MM, Chen YB.) Blood. 2025 May 08;145(19):2138-2148 PMID: 39775763 PMCID: PMC12105721 01/08/2025

  • (Holtan SG, Bolaños-Meade J, Al Malki MM, Wu J, Kitko CL, Reshef R, Rezvani AR, Shaffer BC, Solh MM, Yao JM, Runaas L, Elmariah H, Larkin KT, El Jurdi N, Gooptu M, Loren AW, Hall AC, Alousi AM, Jamy O, Clark W, Kean L, Bhatt AS, Perales MA, Applegate K, Efebera YA, Leifer E, Jones RJ, Horowitz MM, Mattila D, Saber W, Hamadani M, Martens MJ.) J Clin Oncol. 2025 Mar 10;43(8):912-918 PMID: 39752608 PMCID: PMC12124660 SCOPUS ID: 2-s2.0-85214844948 01/03/2025

  • (Kassim AA, Walters MC, Eapen M, Smith M, Logan BR, Solh M, McKinney C, Nieder M, Ross M, Kent M, Abusin GA, Mallhi K, Silva JG, Shaughnessy P, Kanter J, Haines H, Farah R, Khaled YA, Ritzau N, Mendizabal A, Abraham A, Bollard C, Cooke K, de la Fuente J, Hanna R, Horowitz MM, Jordan LC, Bakshi N, Krishnamurti L, Leifer E, Mahadeo KM, Shenoy S, Jones RJ, DeBaun MR, Brodsky RA.) NEJM Evid. 2025 Mar;4(3):EVIDoa2400192 PMID: 39998298 PMCID: PMC11932095 02/25/2025

  • (Kaur M, Horowitz MM, Mendizabal A, Chen M, Foley A, Auletta JJ, Devine S, D'Souza A.) Transplant Cell Ther. 2025 Jan;31(1):49-57 PMID: 39489220 PMCID: PMC11735273 SCOPUS ID: 2-s2.0-85211189246 11/04/2024

  • (Eapen M, Antin JH, Tolar J, Arai S, Horwitz ME, Kou J, Leifer E, McCarty JM, Nakamura R, Pulsipher MA, Rowley SD, Horowitz MM, Deeg HJ.) EClinicalMedicine. 2024 Oct;76:102819 PMID: 39290639 PMCID: PMC11405822 09/18/2024

  • (Eapen M, Antin JH, Tolar J, Arai S, Horwitz ME, Kou J, Leifer E, McCarty JM, Nakamura R, Pulsipher MA, Rowley SD, Horowitz MM, Deeg HJ.) Eclinicalmedicine. October 2024;76 SCOPUS ID: 2-s2.0-85202953543 10/01/2024

Publications of from the

© 2025 ¶¶زُ¶جتسئµ.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The ¶¶زُ¶جتسئµ (¶¶زُ¶جتسئµ) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. ¶¶زُ¶جتسئµ maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

¶¶زُ¶جتسئµ's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the ¶¶زُ¶جتسئµ community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.